Renal transplantation in patients with IgA mesangial glomerulonephritis

Pediatric Transplantation

Volumn 8, Issue 4, 2004, Pages 334-338

  Ponticelli, Claudio ^a   Traversi, Lara ^a   Banfi, Giovanni ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

IgA nephritis; Recurrent glomerulonephritis; Renal transplantation

Indexed keywords

CONFERENCE PAPER; DISEASE COURSE; ETHNOLOGY; FOLLOW UP; GRAFT SURVIVAL; HEREDITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVING DONOR; POSTOPERATIVE PERIOD; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME;

CHILD; GLOMERULONEPHRITIS, IGA; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS;

EID: 4043145749     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00177.x     Document Type: Conference Paper

References (40)

1. BERGER J, HINGLAIS N. Les dèpots intercapillaires d'IgA IgG. J Urol Nephrol 1968: 74: 694-700.
2. LEE G, GLASSOCK RJ. Immunoglobulin A nephropathy. In: PONTICELLI C, GLASSOCK RJ, eds. Treatment of Primary Glomerulonephritis. Oxford: Oxford Medical Publications, 1997: pp. 186-217.
3. BERGER J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988: 12: 371-372.
4. SCHWARZ A, KRAUSE PH, OFFERMANN G, KELLER F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991: 5: 524-531.
5. ODUM J, PEH CA, CLARKSON AR, et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994: 9: 309-312.
6. HARTUNG R, LIVINGSTON B, EXCELL L, DISNEY A, WOODROFFE AJ. Recurrence of IgA deposits/disease in grafts. Contrib Nephrol 1995: 111: 13-16.
7. KIM YS, JEONG HJ, CHOI KH, et al. Renal transplantation in patients with IgA nephropathy. Transplant Proc 1996: 28: 1543-1544.
8. FROHNERT PP, DONADIO JV, VELOSA JA, HOLLEY KE, STERIOFF S. The fate of renal transplant in patients with IgA nephropathy. Clin Transplant 1997: 11: 127-133.
9. OHMACHT C, KLIEM V, BURG M, et al. Recurrent immunoglobulin A nephropathy after renal transplantation. Transplantation 1997: 64: 1493-1496.
10. BUMGARDNER GL, AMEND WC, ASCHER NL, VINCENTI FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998: 65: 1053-1060.
11. FREESE P, SVALANDER C, NORDEN G, NYBERG G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999: 13: 313-317.
12. HARIHARAN S, ADAMS MB, BRENNAN DC, et al. Recurrent and de novo glomerular disease after renal transplantation. Transplantation 1999: 69: 635-641.
13. PONTICELLI C, TRAVERSI L, FELICIANI A, CESANA B, BANFI G, TARANTINO A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001: 60: 1948-1954.
14. CHOY BY, CHAN TM, LO SK, LAI KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003: 18: 2399-2404.
15. ANDRESDOTTIR MB, HOITSMA AJ, ASSMANN KJ, WETZELS JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001: 56: 279-288.
16. BERTHOUX FC, GAGNE A, SABATIER JC, et al. HLA BW38 and mesangial IgA glomerulonephritis. N Engl J Med 1978: 298: 1034-1035.
17. BRENSILVER JM, MALLAT S, SCHOLES J, MCCABE R. Recurrent IgA nephropathy in living related donor transplantation: Recurrence or trasmission of familial disease? Am J Kidney Dis 1988: 12: 147-151.
18. BACHMAN U, BIAVA C, AMEND W, et al. The clinical course of IgA nephropathy and Henoch Schonlein purpura following renal transplantation. Transplantation 1986: 42: 511-515.
19. TOMLANOVICH S, VINCENTI F, AMEND W, et al. Is cyclosporine effective in preventing recurrence of immunomediated glomerular disease after renal transplantation? Transplant Proc 1988: 20(Suppl. 4): 285-288.
20. KESSLER M, HIESSE C, HESTIN D, MAYEUX D, BOUBENIDER K, CHARPENTIER B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996: 28: 99-104.
21. MONTEIRO RC, CHEVAILLER A, NOËL LH, LESAVRE P. Serum IgA preferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 1988: 73: 300-306.
22. LESAVRE P, DIGEON M, BACH JF. Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 1982: 48: 61-69.
23. COPPO R, AMORE A, CIRINA P, et al. IgA serology in recurrent and non recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 1995: 10: 2310-2315.
24. LIM EC, CHIA D, TERASAKI PI. Studies of sera from IgA nephropathy patients to explain high kidney graft survival. Hum Immunol 1991: 32: 81-86.
25. ALAMARTINE E, BOULHAROUZ R, BERTHOUX F. Actuarial survival rate of kidney transplant in patients with IgA glomerulonephritis. A one-center study. Transplant Proc 1994: 26: 272.
26. LIM EC, CHIA D, GJERTSON DW, KOKA P, TERASAKI PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993: 55: 996-999.
27. O'MEARA Y, GREEN A, CARMODY M, et al. Recurrent glomerulonephritis in renal transplant: Fourteen years experience. Nephrol Dial Transplant 1989: 4: 730-734.
28. PETTERSSON EE, REKOLA S, BERGLUND L, et al. Treatment of IgA nephropathy with omega-3 polyunsaturated fatty acids: A prospective, double-blind, randomized study. Clin Nephrol 1994: 41: 183-190.
29. BENNETT WM, WALKER RG, KINCAID-SMITH P. Treatment of IgA nephropathy with eicosapentaenoic acid (EPA): a two-year prospective trial. Clin Nephrol 1989: 31: 128-131.
30. DONADIO JV, GRANDE JP, BERGSTRALH EJ, DART RA, LARSON TS. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol 1999: 10: 1772-1777.
31. DONADIO JV, LARSON TS, BERGSTRALH EJ, GRANDE JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001: 12: 791-799.
32. POZZI C, BOLASCO P, FOGAZZI G, et al. Corticosteroid in IgA nephropathy: A randomized controlled trial. Lancet 1999: 353: 883-887.
33. YOSHIKAWA N, ITO H, SAKAI T, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 1999: 10: 101-109.
34. MASCHIO G, CAGNOLI L, CLARONI F, et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994: 9: 265-269.
35. CATTRAN DC, GREENWOOD C, RITCHIE S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994: 23: 247-254.
36. OKA K, IMAI E, MORIYAMA T, et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of ACE-Inhibitor. Nephrol Dial Transplant 2000: 15: 689-695.
37. JEONG HJ, KIM YS, KWON KW, et al. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: Relationship with proteinuria and therapeutic response to enalapril. Clin Transplant 2003: 17: 108-113.
38. KIMATA N, TANABE K, ISHIKAWA N, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc 1996: 28: 1537-1539.
39. BUTANI L, PALMER J. Effect of fish oil in a patient with posttransplantation IgA nephropathy. Nephrol Dial Transplant 2000: 15: 1264-1265.
40. NG R. Fish oil therapy in recurrent IgA nephropathy. Ann Intern Med 2003: 138: 1011-1012.